7 May 2021 (Friday) - ASH Update


The American Society of Hematology sent a spotlight on clotting disorders today:

High- and Low-Dose Rivaroxaban Versus Aspirin for Women With VTE and Heavy Menstrual Bleeding
Results published in Research and Practice in Thrombosis and Haemostasis show no statistically significant difference in menstrual hemorrhage in patients with VTE who are treated with rivaroxaban at 10 mg or 20 mg, compared with aspirin.
Reduced Calf Muscle Pump Function Predicts VTE and Mortality Risk
According to a study published in Blood, reduced calf pump function appears to be a risk factor for venous thromboembolism and an independent predictor of all-cause mortality.
How I Treat VTE in Pregnancy
Saskia Middeldorp, MD, PhD, and Wessel Ganzevoort, MD, PhD, discuss the diagnosis, treatment, and prevention of venous thromboembolism in pregnant women.


No comments:

Post a Comment